Accordingly, the CD8:Treg and CD4:Treg ratios were higher in treated tumors (p = 0.01; Figure 6E), suggesting that preoperative therapy may specifically deplete immunosuppressive cell types in the PDA tumor microenvironment. The gene discussed is CD8A; the disease is Patent ductus arteriosus.